Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals.
暂无分享,去创建一个
Tom Reynders | Elizabeth Rosenberg | C. Beals | M. Malice | E. Kauh | S. Ramael | L. Mixson | M. Ruddy | Steven Ramael | Eunkyung Kauh | Lori Mixson | Marie-Pierre Malice | Sofie Mesens | Joanne Burke | Kristien Van Dyck | Chan Beals | Marcella Ruddy | E. Rosenberg | K. van Dyck | T. Reynders | S. Mesens | Joanne Burke
[1] K. Asadullah,et al. Selective glucocorticoid receptor agonists (SEGRAs): Novel ligands with an improved therapeutic index , 2007, Molecular and Cellular Endocrinology.
[2] A. Kay,et al. The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen‐induced cutaneous late‐phase reactions in atopic subjects , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[3] H. Taniguchi,et al. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. , 2004, Biochemical and biophysical research communications.
[4] C. Cooper,et al. The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis , 2002, Osteoporosis International.
[5] S. Gabriel,et al. Posttransplantation diabetes: a systematic review of the literature. , 2002, Diabetes care.
[6] Andrea Mari,et al. A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .
[7] P. Schneiter,et al. Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans. , 1998, American journal of physiology. Endocrinology and metabolism.
[8] Andrea Mari,et al. Methods for clinical assessment of insulin sensitivity and beta-cell function. , 2003, Best practice & research. Clinical endocrinology & metabolism.
[9] Hang Lee,et al. Effects of Low‐Dose Prednisone on Bone Metabolism , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] J. Bilezikian,et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy , 2007, Osteoporosis International.
[11] T. Uzu,et al. Glucocorticoid-Induced Diabetes Mellitus: Prevalence and Risk Factors in Primary Renal Diseases , 2006, Nephron Clinical Practice.
[12] T. Staa. The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis , 2006, Calcified Tissue International.
[13] Delta Rn. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. , 2008 .
[14] A. Waage,et al. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. , 1988, Immunology.
[15] S. Al Snih,et al. Effect of low-dose prednisone on leukocyte counts and subpopulations in patients with rheumatoid arthritis. , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[16] C. Lamberg-Allardt,et al. Effects of 3 weeks' moderate alcohol intake on bone and mineral metabolism in normal men. , 1991, Bone and mineral.
[17] T. van Staa. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. , 2006, Calcified tissue international.
[18] S. Kawano,et al. Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study , 2008, Journal of Bone and Mineral Metabolism.
[19] J. Levy,et al. Use and abuse of HOMA modeling. , 2004, Diabetes care.
[20] Andrea Mari,et al. Methods for clinical assessment of insulin sensitivity and β-cell function , 2003 .
[21] C. Akdis,et al. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma , 1997, Allergy.
[22] H. Houben,et al. Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers. , 1998, British journal of rheumatology.
[23] K. Ohnaka,et al. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. , 2005, Biochemical and biophysical research communications.
[24] J. Bollerslev,et al. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. , 1998, Bone.
[25] P. Frith,et al. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. , 2011, The Journal of clinical endocrinology and metabolism.
[26] A. Kagey‐Sobotka,et al. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. , 1991, Journal of immunology.
[27] S. Herzig,et al. Glucocorticoids, metabolism and metabolic diseases , 2007, Molecular and Cellular Endocrinology.
[28] R. Cameron,et al. A comparison of the effects of oral prednisone and inhaled beclomethasone dipropionate on circulating leukocytes. , 1996, Australian and New Zealand journal of medicine.
[29] D. Ouwens,et al. Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options? , 2009, European journal of clinical investigation.
[30] C. Brideau,et al. The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor‐α and leukotriene B4 in a novel human whole blood assay , 1999, British journal of pharmacology.
[31] Khusru Asadullah,et al. Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.
[32] R. Downs,et al. Effect of short‐term glucocorticoids on serum osteocalcin in healthy young men , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] S. Durham,et al. Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen‐induced late cutaneous responses , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[34] R. Civitelli,et al. Epidemiology of glucocorticoid-induced osteoporosis. , 2008, Journal of endocrinological investigation.
[35] R. D. de Nijs. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. , 2008, Minerva medica.
[36] P. Pouwels,et al. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial , 2011, Diabetologia.